Back to results
US 2011/0237499 A1Published application
Hybrid tripyrrole-octaarginine compounds and their use as medicament in the treatment of cancer and microbial illnesses
OwnerEugenio Vazquez Sentis, Juan Bautista Blanco Canosa +3inventors
InventorsEugenio Vazquez Sentis, Juan Bautista Blanco Canosa, Jose Martinez Costas, Jose Luis Mascarena Cid, Luis Castedo Exposito
Life of this patent
Estimating the term…
Abstract
Hybrid tripyrrole-octaarginine compounds. Hybrids formed by a tripyrrole group bound to a polyarginine peptide which permit the efficient cellular internalization and promote a greater affinity for the DNA. The method of obtainment and uses thereof.
Claims12
A compound comprising a tripyrrole group bound to an octaarginine ((Arg)8) by means of a spacer, wherein the spacer comprises at least one lysine (Lys).
Dependencies are inferred from the claim text.